Trials / Conditions / Peanut Hypersensitivity

Peanut Hypersensitivity

21 registered clinical trials studyying Peanut Hypersensitivity — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic NCT05695261	Rima Rachid	Phase 2
Active Not Recruiting	A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy NCT05621317	Aravax Pty Ltd	Phase 2
Completed	Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE) NCT03679676	Stanford University	Phase 2
Completed	Boiled Peanut Oral Immunotherapy NCT04090203	Alton Melton	Phase 1
Active Not Recruiting	Boiled Peanut Immunotherapy for the Treatment of Peanut Allergy NCT03937726	Imperial College London	N/A
Completed	Mechanisms Underlying Peanut Allergic Reactions in TRACE Peanut Study Participants: Extension Study NCT02665793	Imperial College London	N/A
Completed	PEAnut Anaphylaxis Predictors NCT02424136	John Hunter Children's Hospital	N/A
Completed	FARE Peanut SLIT and Early Tolerance Induction NCT02304991	University of North Carolina, Chapel Hill	Phase 2
Completed	Peanut Epicutaneous Phase II Immunotherapy Clinical Trial NCT01904604	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	Peanut Oral Immunotherapy in Children NCT01867671	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Unknown	The Effect of Extrinsic Factors on Food Allergy NCT01429896	Cambridge University Hospitals NHS Foundation Trust	Phase 2
Completed	Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance NCT01373242	University of North Carolina, Chapel Hill	Phase 1 / Phase 2
Completed	A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment NCT01084174	Johns Hopkins University	Phase 1 / Phase 2
Completed	Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults NCT00850668	Allertein Therapeutics, LLC	Phase 1
Completed	Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy NCT00932282	University of North Carolina, Chapel Hill	Phase 1 / Phase 2
Completed	Oral Immunotherapy (OIT) for Peanut Allergy NCT00815035	University of North Carolina, Chapel Hill	Phase 2
Completed	A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial NCT00580606	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1 / Phase 2
Completed	A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788g NCT00382148	Genentech, Inc.	Phase 2
Completed	An Observational Study of Childhood Food Allergy NCT00356174	National Institute of Allergy and Infectious Diseases (NIAID)	—
Completed	Oral Peanut Immunotherapy for Peanut Allergic Patients NCT01891136	University of North Carolina, Chapel Hill	EARLY_Phase 1
Unknown	Development of an Algorithm to Better Predict Clinical Responsiveness to Peanut NCT00243555	Hamilton Health Sciences Corporation	—